GlassScriptPhysician profile
Maureen S Clinch
NPI 1467416339
$5,381.03
in general payments reported to CMS, 2019-2025
21 companies · $657 in 2025
The $657 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $913 · 2020: $200 · 2021: $309 · 2022: $710 · 2023: $1,756 · 2024: $836 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,324 · Travel and Lodging: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,324.12 |
| Travel and Lodging | $925.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,800.65 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $654.84 | 2019-2025 | Grafix, Collagenase Santyl, Regranex |
| Organogenesis INC. | $400.53 | 2020-2025 | Puraply Wound Matrix, Apligraf |
| Treace Medical Concepts, INC. | $331.80 | 2024-2025 | |
| Eclipse Technology Solutions INC. | $297.35 | 2023-2024 | |
| Acera Surgical, INC. | $191.51 | 2025 | Restrata Wound Matrix |
| Stryker Corporation | $166.96 | 2019-2022 | |
| Kci USA, INC. | $134.87 | 2021-2022 | |
| Solventum Corporation | $86.52 | 2024-2025 | Activ.A.C., Promogran Prisma |
| Paratek Pharmaceuticals, INC. | $60.37 | 2023-2024 | Nuzyra |
| Kerecis Limited | $39.46 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Osiris Therapeutics INC. | $39.35 | 2019 | |
| Inari Medical, INC. | $32.46 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zimmer Biomet Holdings, INC. | $30.96 | 2021 | |
| Convatec INC. | $22.34 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $19.99 | 2019 | |
| Wright Medical Technology, INC. | $19.86 | 2020 | |
| Glaxosmithkline, LLC. | $14.75 | 2020 | |
| Paragon 28, INC. | $12.45 | 2019 | |
| Cashflow Solutions, LLC | $12.16 | 2024 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Misonix INC | $11.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Clinch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.